DrugDashboards

Olanzapine and Fluoxetine

Olanzapine and Fluoxetine · OLANZAPINE 12 mg/1; FLUOXETINE HYDROCHLORIDE 50 mg/1 · Capsule · Oral · AvKARE

NDC 42291-0656-30 · 30 CAPSULE in 1 BOTTLE · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$510.57
Reported to Texas DSHS · 2026 annual filing · AvKare

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.1%chance of a new FDA shortage posting for olanzapine and fluoxetine (oral solid) in the next 90 days

sole-source market

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program · Zyprexa Relprevv

Regulatory

Application
ANDA077528
TE code
AB
Approval date
Jun 19, 2012
Patents / exclusivity
None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Olanzapine and Fluoxetine (Capsule)

LabelerStrengthFirst seenLast seen
AvKAREOLANZAPINE 12 mg/1; FLUOXETINE HYDROCHLORIDE 50 mg/1Aug 26, 2026Sep 2, 2026
AvKAREOLANZAPINE 6 mg/1; FLUOXETINE HYDROCHLORIDE 50 mg/1Aug 26, 2026Sep 2, 2026
AvKAREOLANZAPINE 6 mg/1; FLUOXETINE HYDROCHLORIDE 25 mg/1Aug 26, 2026Sep 2, 2026
AvKAREOLANZAPINE 3 mg/1; FLUOXETINE HYDROCHLORIDE 25 mg/1Aug 26, 2026Sep 2, 2026
AvKAREOLANZAPINE 12 mg/1; FLUOXETINE HYDROCHLORIDE 25 mg/1Aug 26, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.OLANZAPINE 6 mg/1; FLUOXETINE HYDROCHLORIDE 25 mg/1Aug 26, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.OLANZAPINE 12 mg/1; FLUOXETINE HYDROCHLORIDE 25 mg/1Aug 26, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.OLANZAPINE 12 mg/1; FLUOXETINE HYDROCHLORIDE 50 mg/1Aug 26, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.OLANZAPINE 6 mg/1; FLUOXETINE HYDROCHLORIDE 50 mg/1Aug 26, 2026Sep 2, 2026
Teva Pharmaceuticals USA, Inc.OLANZAPINE 3 mg/1; FLUOXETINE HYDROCHLORIDE 25 mg/1Aug 26, 2026Sep 2, 2026
AvKAREOLANZAPINE 25 mg/1; FLUOXETINE HYDROCHLORIDE 12 mg/1Jul 22, 2026Aug 19, 2026
AvKAREOLANZAPINE 50 mg/1; FLUOXETINE HYDROCHLORIDE 6 mg/1Jul 22, 2026Aug 19, 2026
AvKAREOLANZAPINE 50 mg/1; FLUOXETINE HYDROCHLORIDE 12 mg/1Jul 22, 2026Aug 19, 2026
AvKAREOLANZAPINE 25 mg/1; FLUOXETINE HYDROCHLORIDE 6 mg/1Jul 22, 2026Aug 19, 2026
AvKAREOLANZAPINE 25 mg/1; FLUOXETINE HYDROCHLORIDE 3 mg/1Jul 22, 2026Aug 19, 2026
Teva Pharmaceuticals USA, Inc.OLANZAPINE 25 mg/1; FLUOXETINE HYDROCHLORIDE 12 mg/1Jul 22, 2026Aug 19, 2026
Teva Pharmaceuticals USA, Inc.OLANZAPINE 25 mg/1; FLUOXETINE HYDROCHLORIDE 3 mg/1Jul 22, 2026Aug 19, 2026
Teva Pharmaceuticals USA, Inc.OLANZAPINE 25 mg/1; FLUOXETINE HYDROCHLORIDE 6 mg/1Jul 22, 2026Aug 19, 2026
Teva Pharmaceuticals USA, Inc.OLANZAPINE 50 mg/1; FLUOXETINE HYDROCHLORIDE 12 mg/1Jul 22, 2026Aug 19, 2026
Teva Pharmaceuticals USA, Inc.OLANZAPINE 50 mg/1; FLUOXETINE HYDROCHLORIDE 6 mg/1Jul 22, 2026Aug 19, 2026
AvKAREFLUOXETINE HYDROCHLORIDE 50 mg/1; OLANZAPINE 12 mg/1Jul 15, 2026Jul 15, 2026
AvKAREFLUOXETINE HYDROCHLORIDE 25 mg/1; OLANZAPINE 12 mg/1Jul 15, 2026Jul 15, 2026
AvKAREFLUOXETINE HYDROCHLORIDE 25 mg/1; OLANZAPINE 6 mg/1Jul 15, 2026Jul 15, 2026
AvKAREFLUOXETINE HYDROCHLORIDE 25 mg/1; OLANZAPINE 3 mg/1Jul 15, 2026Jul 15, 2026
AvKAREFLUOXETINE HYDROCHLORIDE 50 mg/1; OLANZAPINE 6 mg/1Jul 15, 2026Jul 15, 2026
Teva Pharmaceuticals USA, Inc.FLUOXETINE HYDROCHLORIDE 25 mg/1; OLANZAPINE 3 mg/1Jul 15, 2026Jul 15, 2026
Teva Pharmaceuticals USA, Inc.FLUOXETINE HYDROCHLORIDE 50 mg/1; OLANZAPINE 12 mg/1Jul 15, 2026Jul 15, 2026
Teva Pharmaceuticals USA, Inc.FLUOXETINE HYDROCHLORIDE 25 mg/1; OLANZAPINE 6 mg/1Jul 15, 2026Jul 15, 2026
Teva Pharmaceuticals USA, Inc.FLUOXETINE HYDROCHLORIDE 25 mg/1; OLANZAPINE 12 mg/1Jul 15, 2026Jul 15, 2026
Teva Pharmaceuticals USA, Inc.FLUOXETINE HYDROCHLORIDE 50 mg/1; OLANZAPINE 6 mg/1Jul 15, 2026Jul 15, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Olanzapine and Fluoxetine — NDC 42291-0656-30," retrieved September 3, 2026, https://drugdashboards.com/drug/42291065630.

Free to cite with attribution — see how the data is put together.